Hansen, F.J.; David, P.; Akram, M.; Knoedler, S.; Mittelstädt, A.; Merkel, S.; Podolska, M.J.; Swierzy, I.; Roßdeutsch, L.; Klösch, B.;
et al. Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients. Cancers 2023, 15, 363.
https://doi.org/10.3390/cancers15020363
AMA Style
Hansen FJ, David P, Akram M, Knoedler S, Mittelstädt A, Merkel S, Podolska MJ, Swierzy I, Roßdeutsch L, Klösch B,
et al. Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients. Cancers. 2023; 15(2):363.
https://doi.org/10.3390/cancers15020363
Chicago/Turabian Style
Hansen, Frederik J., Paul David, Marina Akram, Samuel Knoedler, Anke Mittelstädt, Susanne Merkel, Malgorzata J. Podolska, Izabela Swierzy, Lotta Roßdeutsch, Bettina Klösch,
and et al. 2023. "Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients" Cancers 15, no. 2: 363.
https://doi.org/10.3390/cancers15020363
APA Style
Hansen, F. J., David, P., Akram, M., Knoedler, S., Mittelstädt, A., Merkel, S., Podolska, M. J., Swierzy, I., Roßdeutsch, L., Klösch, B., Kouhestani, D., Anthuber, A., Bénard, A., Brunner, M., Krautz, C., Grützmann, R., & Weber, G. F.
(2023). Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients. Cancers, 15(2), 363.
https://doi.org/10.3390/cancers15020363